Maria Vistnes
- Senior Cardiologist; MD, PhD
- +47 95 87 51 14
Mini CV
- Senior Cardiologist, Postdoctoral researcher, MD, PhD
- +47 95 87 51 14
- maria.vistnes@medisin.uio.no
Education
- Certified specialist in Cardiology (2023)
- PhD, Faculty of Medicine, University of Oslo (2012)
- MD, University of Oslo (2010)
Work record (selected)
- Consultant Cardiologist, Cardiology Department, Oslo University Hospital Ullevål (2023 – present)
- Postdoctoral candidate, Cardiology Department, Oslo University Hospital Ullevål (2023 - present)
- Postdoctoral candidate, Institute for Experimental Medical Research, Oslo University Hospital (2018 – 2023)
- Researcher, Institute for Experimental Medical Research, Oslo University Hospital (2015 – 2018)
- Resident in Internal Medicine and Cardiology, Diakonhjemmet Hospital (2013 - 2018)
Awards, committees, memberships
- SPARK innovation program, University of Oslo (2019-2022)
- Working Group for heart failure, Norwegian Society of Cardiology (2021 – present)
- Quality Panel for assessment of ESC guidelines on heart failure (2021 and 2023)
Other
- Main supervisor for PhD student Simon Andrup, Faculty of Medicine, University of Oslo (2020 – present)
- Co-supervisor for PhD student Athiramol Sasi, Faculty of Medicine, University of Oslo (2019 – present)
Research Areas
- Heart failure mechanisms, in particular extracellular matrix and fibrosis
- Quantification of biomarkers, including new methods and assay development
- Innovation and commercialization, development of new therapies
- Remote patient monitoring (“Digital hjemmeoppfølging”)
Publications 2024
Novel cardiac extracellular matrix biomarkers in STEMI: Associations with ischemic injury and long-term mortality
PLoS One, 19 (5), e0302732
DOI 10.1371/journal.pone.0302732, PubMed 38739599
High-sensitive troponinT, interleukin-8, and interleukin-6 link with post-surgery risk in infant heart surgery
Acta Anaesthesiol Scand, 68 (6), 745-752
DOI 10.1111/aas.14405, PubMed 38531618
Survival of the strongest: can muscular strength measurements be used in prevention of heart failure in patients with acute coronary syndromes?
Eur J Prev Cardiol, 31 (7), 832-833
DOI 10.1093/eurjpc/zwae047, PubMed 38381591
Hitting the Target! Challenges and Opportunities for TGF-β Inhibition for the Treatment of Cardiac fibrosis
Pharmaceuticals (Basel), 17 (3)
DOI 10.3390/ph17030267, PubMed 38543053
Publications 2023
Temporal expression and spatial distribution of the proteoglycan versican during cardiac fibrosis development
Matrix Biol Plus, 19-20, 100135
DOI 10.1016/j.mbplus.2023.100135, PubMed 38076279
How can we improve the follow-up of patients with heart failure?
Tidsskr Nor Laegeforen, 143 (17)
DOI 10.4045/tidsskr.23.0735, PubMed 37987060
Inhibition of the extracellular enzyme A disintegrin and metalloprotease with thrombospondin motif 4 prevents cardiac fibrosis and dysfunction
Cardiovasc Res, 119 (10), 1915-1927
DOI 10.1093/cvr/cvad078, PubMed 37216909
Publications 2022
Associations of Body Mass Index With Pain and the Mediating Role of Inflammatory Biomarkers in People With Hand Osteoarthritis
Arthritis Rheumatol, 74 (5), 810-817
DOI 10.1002/art.42056, PubMed 35137553
Publications 2021
Levosimendan Versus Milrinone and Release of Myocardial Biomarkers After Pediatric Cardiac Surgery: Post Hoc Analysis of Clinical Trial Data
Pediatr Crit Care Med, 22 (7), e402-e409
DOI 10.1097/PCC.0000000000002712, PubMed 33739957
Publications 2020
The Association Between Circulating Inflammatory Markers and the Progression of Alzheimer Disease in Norwegian Memory Clinic Patients With Mild Cognitive Impairment or Dementia
Alzheimer Dis Assoc Disord, 34 (1), 47-53
DOI 10.1097/WAD.0000000000000342, PubMed 31414991
Obstructive sleep apnea versus central sleep apnea: prognosis in systolic heart failure
Cardiovasc Diagn Ther, 10 (3), 396-404
DOI 10.21037/cdt.2020.03.02, PubMed 32695620
Correlation of Body Weight and Composition With Hepatic Activities of Cytochrome P450 Enzymes
J Pharm Sci, 110 (1), 432-437
DOI 10.1016/j.xphs.2020.10.027, PubMed 33091408
Publications 2019
Annual decline in forced expiratory volume and airway inflammatory cells and mediators in a general population-based sample
BMC Pulm Med, 19 (1), 90
DOI 10.1186/s12890-018-0765-7, PubMed 31072364
The Effect of Levosimendan Versus Milrinone on the Occurrence Rate of Acute Kidney Injury Following Congenital Heart Surgery in Infants: A Randomized Clinical Trial
Pediatr Crit Care Med, 20 (10), 947-956
DOI 10.1097/PCC.0000000000002017, PubMed 31274775
Publications 2018
Associations between Cytokine Levels and CYP3A4 Phenotype in Patients with Rheumatoid Arthritis
Drug Metab Dispos, 46 (10), 1384-1389
DOI 10.1124/dmd.118.082065, PubMed 29991576
Publications 2017
Plasma immunological markers in pregnancy and cord blood: A possible link between macrophage chemo-attractants and risk of childhood type 1 diabetes
Am J Reprod Immunol, 79 (3)
DOI 10.1111/aji.12802, PubMed 29266506
Publications 2016
A retrospective analysis of cardiovascular outcomes in patients treated with ASV
Scand Cardiovasc J, 51 (2), 106-113
DOI 10.1080/14017431.2016.1262546, PubMed 27854123
Midpregnancy and cord blood immunologic biomarkers, HLA genotype, and pediatric celiac disease
J Allergy Clin Immunol, 139 (5), 1696-1698
DOI 10.1016/j.jaci.2016.10.016, PubMed 27865861
Publications 2014
Increased levels of eotaxin and MCP-1 in juvenile dermatomyositis median 16.8 years after disease onset; associations with disease activity, duration and organ damage
PLoS One, 9 (3), e92171
DOI 10.1371/journal.pone.0092171, PubMed 24647150
In active juvenile dermatomyositis, elevated eotaxin and MCP-1 and cholesterol levels in the upper normal range are associated with cardiac dysfunction
Rheumatology (Oxford), 53 (12), 2214-22
DOI 10.1093/rheumatology/keu256, PubMed 24996906
Pentosan polysulfate decreases myocardial expression of the extracellular matrix enzyme ADAMTS4 and improves cardiac function in vivo in rats subjected to pressure overload by aortic banding
PLoS One, 9 (3), e89621
DOI 10.1371/journal.pone.0089621, PubMed 24595230
Publications 2013
Innate immune signaling induces expression and shedding of the heparan sulfate proteoglycan syndecan-4 in cardiac fibroblasts and myocytes, affecting inflammation in the pressure-overloaded heart
FEBS J, 280 (10), 2228-47
DOI 10.1111/febs.12161, PubMed 23374111
Publications 2012
Circulating cytokine concentrations are not associated with major depressive disorder in a community-based cohort
Gen Hosp Psychiatry, 34 (3), 262-7
DOI 10.1016/j.genhosppsych.2012.01.017, PubMed 22401706
Macrophage inflammatory protein-1β: a novel prognostic biomarker in atherosclerosis?
Cardiology, 121 (3), 149-51
DOI 10.1159/000336484, PubMed 22441313
Chemokines regulate small leucine-rich proteoglycans in the extracellular matrix of the pressure-overloaded right ventricle
J Appl Physiol (1985), 112 (8), 1372-82
DOI 10.1152/japplphysiol.01350.2011, PubMed 22345433
Publications 2010
Multiple cytokine biomarkers in heart failure
Expert Rev Mol Diagn, 10 (2), 147-57
DOI 10.1586/erm.10.3, PubMed 20214534
Circulating cytokine levels in mice with heart failure are etiology dependent
J Appl Physiol (1985), 108 (5), 1357-64
DOI 10.1152/japplphysiol.01084.2009, PubMed 20224000